Skip to main content

Advertisement

SpringerLink
Log in

‘K culture’, ketamine’s prominent yet overlooked role on the Irish drug scene and implications for health

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ivers JI, Killeen N, Keenan K (2021) Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival attendees. Ir J Med Sci 191(4):1701–1710. https://doi.org/10.1007/s11845-021-02765-2

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mongan D, Killeen N, Evans D et al (2022) European web survey on drugs 2021: Irish results. Dublin: Health Research Board

  3. Killeen N, Corrigan N, Keenan E (2023) The HSE ‘Safer Nightlife’ Programme 2022. Volunteer feedback on the provision of harm reduction outreach in Irish festival settings. Dublin: Health Service Executive

  4. Moore K, Measham F (2008) It’s the most fun you can have for twenty quid: meanings, motivations, and consequences of British ketamine use. Addiction Research and Theory, Special Issue: Social and Cultural Aspects of Ketamine Use. 16(3)

  5. Griffin C, Measham F, Moore F et al (2008) Editorial: Social and cultural uses of ketamine. Addiction research and theory, special issue: social and cultural uses of ketamine. 16(3)

  6. Byrne M, Dick S, Ryan L, Dockray S, Davoren MP, Heavin C, Ivers JI, Linehan C, Vasilisou VS (2022) The Drug Use in Higher Education in Ireland (DUHEI) survey 2021: main findings. Cork: University College Cork. http://www.drugsandalcohol.ie/35515/

  7. European Monitoring Centre for Drugs and Drug Addiction (2023) European drug report 2023 trends and developments, other drugs – the current situation in Europe. Publications Office of the European Union. http://www.emcdda.europa.eu/publications/european-drug-report/2023/other-drugs_en

  8. Drugs.ie (2023) Results from back of house drug checking May 2023. Retrieved on September 13, 2023 from: http://www.drugs.ie/results_from_back_of_house_drug_checking_may_2023/

  9. United Nations on Drugs and Crime (2022) “Tuci”, “happy water”, “k-powdered milk” – is the illicit market for ketamine expanding? Global Smart Update, Volume 27. http://www.unodc.org/documents/scientific/Global_SMART_Update_2022_Vol.27.pdf

  10. Beerten SG, Mathei C, Aertgeerts B (2023) Ketamine misuse: an update for primary care. https://doi.org/10.3399/bjgp23X731997.www.ncbi.nlm.nih.gov/pmc/articles/PMC9888585/

  11. European Monitoring Centre for Drugs and Drug Addiction (2002) Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Publications Office of the European Union. http://www.emcdda.europa.eu/publications/risk-assessments/ketamine_en

  12. Dillon P, Copeland J, Jansen K (2003) Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 69(1):23–8. https://doi.org/10.1016/s0376-8716(02)00243-0. PMID: 12536063

  13. Abdulrahim D, Bowden-Jones O (2015) On behalf of the NEPTUNE Expert Group. Guidance on the Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances. Novel Psychoactive Treatment UK Network (NEPTUNE). London. http://www.drugsandalcohol.ie/24292/

  14. Orhurhu VJ, Vashisht R, Claus LE, Cohen SP (2023) Ketamine toxicity. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: http://www.ncbi.nlm.nih.gov/books/NBK541087/

  15. Rosenbaum SB, Gupta V, Patel P, Palacios JL (2023) Ketamine. May 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 29262083

  16. Kalsi SS, Wood DM, Dargan PI (2011) The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 4:7107. https://doi.org/10.3402/ehtj.v4i0.7107. PMID: 24149025; PMCID: PMC3168228

Download references

Author information

Authors and Affiliations

  1. HSE National Social Inclusion Office, Dublin, Ireland

    Nicki Killeen & Eamon Keenan

  2. HSE National Drug Treatment Centre, Dublin, Ireland

    Sinéad Mc Namara

  3. Public Health and Primary Care, School of Medicine, Trinity College Dublin, Dublin, Ireland

    Eamon Keenan

Authors
  1. Nicki Killeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sinéad Mc Namara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eamon Keenan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NK: conceptualisation, original draft, writing, editing; SMN: provision of scientific findings, reviewing and editing; EK: reviewing and editing.

Corresponding author

Correspondence to Nicki Killeen.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Killeen, N., Mc Namara, S. & Keenan, E. ‘K culture’, ketamine’s prominent yet overlooked role on the Irish drug scene and implications for health. Ir J Med Sci (2023). https://doi.org/10.1007/s11845-023-03590-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11845-023-03590-5

Search

Navigation